Global Biosynthesis of Cannabinoids Market Size By Type (Balanced THC And CBD, Cannabidiol Dominant, THC Dominant), By Application (Pain Management, Anxiety Management, Appetite Stimulation, Nausea Management), By Geographic Scope And Forecast

Biosynthesis of Cannabinoids Market Size And Forecast

Biosynthesis of Cannabinoids Market size was valued at USD 19,446.06 Million in 2022 and is projected to reach USD 71,524.16 Million by 2030, growing at a CAGR of 14.97% from 2024 to 2030.

Cannabinoids are mostly found in the cannabis plant. Cannabinoids are produced through a biosynthetic process. Also, there is no other option for the biosynthetic process, which has the potential to change the way cannabinoids are produced in the future. Cannabinoids contain oxygenated hydrocarbons and no nitrogen. delta9-THC is a cannabinoid that causes significant psychoactive effects on many medicinal products, a growth driver for the biosynthesis of the cannabinoid industry. The Global Cannabinoid Biosynthesis Market report provides a market analysis. The report provides a comprehensive analysis of key segments, trends, drivers, constraints, competitive landscape and factors that play an important role in doing business.

Global Biosynthesis of Cannabinoids Market Definition

Cannabinoid biosynthesis, which uses simple bacteria to produce the desired substance on a large scale, is now on the verge of expansion. Canadian investment bank ATB Capital believes its technology will improve the commercialization of low-cannabinoid products and adds that it will open the door for pharmaceutical companies and consumers (CPG) to use them as key ingredients in health, wellness, and sports products. Solving the critical problem of producing high-quality products on a large scale does not seem difficult. Cronos, in collaboration with Ginkgo Bio, has successfully fermented cannabinol on a research scale and the product is expected to be commercialized in September 2022.

The simultaneous use of alcohol and marijuana causes adverse effects such as nausea, vomiting, fear, anxiety, and paranoia, which are important for stopping and reducing the growth of commercial cannabinoids. Also, cannabinoids contain oxygenated hydrocarbons and no nitrogen. delta9-THC is a cannabinoid that is an important psychoactive component of many pharmaceutical products, driving growth in the biosynthetic cannabinoid industry. In addition, phytocannabinoids are considered natural products of plants, and endocannabinoids are considered compounds in animals and humans and are endogenous ligands for cannabinoid receptors.

Global Biosynthesis of Cannabinoids Market Overview

Increasing the use of cannabinoids for medicinal purposes may aid in the biosynthetic development of commercial cannabinoids. Natural plant products, such as leaves, seeds, and flowers, are expensive because of their many uses and medicinal value. About 10 kilograms of cannabis plants should produce 2 grams of cannabis. Biosynthetic cannabinoids are more expensive than natural methods. Therefore, the main influence of the environment on cannabinoid production may be the determinant of biosynthetic cannabinoid production. Marijuana is a mixture of marijuana and cannabinoids that a doctor prescribes to a patient.

Due to production and government restrictions, the use of cannabis as a drug has not been rigorously tested, resulting in limited clinical trials to determine the safety and efficacy of cannabis use to treat diseases. Anecdotal evidence suggests that marijuana may reduce nausea and vomiting during pain medication and reduce chronic pain and muscle aches. The medicinal use of the cannabis plant dates back thousands of years in many cultures. Several medical organizations in the United States have requested that marijuana be removed from the United States government-controlled List 1 of controlled substances, pending regulatory and scientific review. Biosynthesis Extraction and export of cannabinoids as raw materials for various medicinal purposes will help the rapid growth of commercial cannabinoid biosynthesis.

Strict Regulations on Cannabis ProductionStrict regulations on the production of the cannabis plant and the increase in demand for medicinal use caused the price of the plant to increase. Many countries have very strict regulations on weed production and therefore weed production is banned in many parts of the world. So this does not directly affect the biosynthesis of the cannabinoid market. Paranoia, palpitations, excessive anxiety, seizures, etc., which natural products do not produce when used for medicinal purposes. It is said to have side effects. Alcohol and cannabis consumption cause adverse effects such as nausea, vomiting, fear, anxiety, and paranoia, which are major inhibitors and slow down the development of cannabinoid biosynthesis.

Global Biosynthesis of Cannabinoids Market Segmentation Analysis

The Global Biosynthesis of Cannabinoids Market is segmented on the basis of Type, Application, and Geography.

Biosynthesis of Cannabinoids Market, By Type

• Balanced THC and CBD
• Cannabidiol Dominant
• THC dominant
• Others

Based on Type, the market is segmented into Balanced THC and CBD, Cannabidiol Dominant, THC dominant, and Others. the THC and CBD segments hold the largest market share. CBD cannabidiol and THC (tetrahydrocannabinol) are the most commonly found cannabidiols in commercial cannabis products. Both THC and CBD are found in marijuana and marijuana. While marijuana has more THC than cannabis, it also has more CBD.

Biosynthesis of Cannabinoids Market, By Application

• Pain Management
• Anxiety Management
• Appetite Stimulation
• Nausea Management

Based on Application, the market is segmented into pain management, anxiety management, appetite stimulation, and nausea management. Cannabinoid drugs are often used to treat mental disorders. Most of the drugs manufactured are for stress management, accounting for 35% of the market share, more than any other drug. Therefore, the stress management department is on the rise compared to other departments.

Biosynthesis of Cannabinoids Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Based on regional analysis, the Global Biosynthesis of Cannabinoids Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Asia-Pacific region has experienced a notable surge in demand for Cannabinoids dominant, CBD-dominant, and THC-dominant cannabinoids due to several key factors. Firstly, there has been a growing awareness and acceptance of the potential therapeutic benefits associated with these cannabinoids. CBD, known for its non-psychoactive properties, has gained popularity for its purported therapeutic effects, such as pain relief, anxiety reduction, and anti-inflammatory properties. THC, on the other hand, known for its psychoactive properties, has been sought after for its recreational use. Secondly, as countries in the Asia-Pacific region have started to embrace the legalization or decriminalization of cannabis for medicinal or recreational purposes, it has opened up opportunities for the production, sale, and consumption of cannabinoids.

This shift in regulations has fueled the demand for both CBD-dominant and THC-dominant products, as consumers seek to explore the potential benefits and recreational experiences associated with these substances. Moreover, the region’s large population, including countries like China and India, plays a significant role in driving the demand. With a growing middle class and increasing disposable incomes, more individuals have the means to access and afford cannabinoid products. This, coupled with the rising trend of wellness and alternative medicine, has led to a surge in demand for cannabinoid-dominant products, catering to a diverse range of consumer preferences and needs. Overall, the combination of increasing awareness, changing regulations, and evolving consumer demographics has contributed to the Asia-Pacific region’s robust demand for cannabinoids dominant, CBD-dominant, and THC-dominant cannabinoids.

Key Players

The “Global Biosynthesis of Cannabinoids Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Hyasynth Biologicals, Amyris Inc, Demetrix, Jazz Pharmaceuticals PLC, Lygos, Renew Biopharma, CB Therapeutics, Canopy Growth Corp, Zymergen Inc, and Cronos Group Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Biosynthesis of Cannabinoids Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Biosynthesis of Cannabinoids Market gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come•